Policybazaar executive Amit Chhabra argues that mandatory health insurance co-payments can improve affordability if expenses remain predictable. This view comes as PB Fintech reports a strong Q2 profit of ₹135 crore, helping the stock recover from recent regulatory-driven volatility. Investors are currently watching how the company navigates potential IRDAI commission caps.
Amit Chhabra, Chief Business Officer of the health insurance vertical at Policybazaar, has highlighted that mandatory co-payments in health insurance could be a tool to enhance market affordability and long-term sustainability. By sharing a portion of medical costs, insurers may be able to offer more competitive premiums, potentially bringing a larger segment of the population into the health insurance fold. However, Chhabra noted that the success of such a model depends heavily on transparency, ensuring that policyholders can predict their out-of-pocket expenses during medical emergencies.
Financial Performance and Business Model
This commentary comes against the backdrop of a strong financial performance for PB Fintech, the parent company of Policybazaar. The company recently reported a consolidated net profit of ₹135 crore for the second quarter of the 2026-27 financial year, marking a 165% year-on-year surge. As a digital-first aggregator, PB Fintech operates an asset-light model. Unlike insurance companies, it does not underwrite policies or hold risk on its books. This structure is central to its business, allowing it to focus on distribution, customer acquisition, and technology, while avoiding the direct balance sheet impact of insurance claims or investment volatility.
Regulatory Sensitivity and Market Reaction
While the company’s financial growth remains robust, its stock price has been sensitive to the broader regulatory landscape. In late September 2026, shares experienced a sharp correction of approximately 36% amid market anxieties regarding proposed IRDAI regulations. These concerns centered on potential changes to distribution rules and commission caps, which could impact the revenue earned per policy and long-term operating margins. The stock has shown signs of recovery in early October, supported by the strong quarterly results which provided reassurance to investors regarding the company's ability to maintain growth momentum despite these regulatory discussions.
Expanding the Insurance Frontier
Beyond the debate on co-payments, the insurance sector is undergoing a geographic and product-led transformation. Data from the industry indicates that 65% to 70% of new business is now originating from Tier-II and Tier-III cities, outpacing growth in major metropolitan areas. To capture this demand, Policybazaar and its peers are focusing on simplifying the claims process, with initiatives like 'Claim Samadhan Diwas' aiming to resolve long-pending cases. Furthermore, as the adoption of electric vehicles increases, insurers are actively building new actuarial models to price risks associated with battery health and repair costs. This evolution is also extending to new categories like cyber and SME insurance, as small businesses increasingly adopt digital infrastructure.
Investor Monitorables
The primary factor investors are tracking remains the clarity from the IRDAI regarding commission structures and expense management. While the company’s Q2 performance highlights operational efficiency, the sustainability of margins will depend on how the aggregator adapts to any upcoming changes in distribution regulations. Investors will likely watch for management commentary on whether the shift toward new business lines, such as SME and cyber insurance, can offset potential pressure on health insurance distribution revenues.